OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Advisory Board and Contents	269
Subscription and Copyright Information	263
Subscription and Copyright Information	228
Advisory Board and Contents	228
Advisory Board and Contents	170
Subscription and Copyright Information	141
Subscription and Copyright Information	141
Fc-optimized checkpoint antibodies for cancer immunotherapy	140
Consideration of the importance of measuring thermal discomfort in biomedical research	137
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	123
Lymph node microenvironment rewires ferroptosis redox defenses	116
Opportunities and challenges for biomarker discovery using electronic health record data	109
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	102
Beneath the radar: immune-evasive cell sources for stroke therapy	102
Neutrophils and extracellular traps in crystal-associated diseases	102
m6A and beyond: RNA modifications shaping angiogenesis	96
Microbiota: a dawn for cancer metastasis therapy	96
The right drug at the right time: key to IBD success	93
Muscle-to-CNS signaling in physiological homeostasis, aging, and disease	92
d-Amino acids: new clinical pathways for brain diseases	88
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	86
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	82
Pushing the boundaries of brain organoids to study Alzheimer’s disease	82
Advisory Board and Contents	82
Brain-specific regulatory T cell expansion limits cognitive decline	81

Erythropoietic protoporphyrias: updates and advances	79
Amyloid and collagen templates in aortic valve calcification	73
Is endometriosis a progressive disease?	73
Hormesis as an adaptive response to infection	71
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	66
Insights from HIV-1 vaccine and passive immunization efficacy trials	66
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	64
Engineering cytokines for tumor-targeting and selective T cell activation	61
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	60
Molecular mechanisms in the pathogenesis of dengue infections	59
Three ‘E’ challenges for siRNA drug development	58
Epigenetic regulation in intervertebral disc degeneration	58
Acquired resistance to immunotherapy in solid tumors	57
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	57
Microbes and mood: innovative biomarker approaches in depression	57
Emerging roles of cyclin-dependent kinase 7 in health and diseases	56
Keratinocytes: new perspectives in inflammatory skin diseases	56
Mitigating age-related somatic mutation burden	55
Promoting proteostasis by cAMP/PKA and cGMP/PKG	54
Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation	54
Tick-borne encephalitis: emerging clinical trends and challenges	53
SOX17: escape route from immune destruction in early CRC	52
Subscription and Copyright Information	52
Subscription and Copyright Information	51
Shining a light on comorbidities	51
Roadmap for developing biologically inspired therapeutics for genetic brain disorders	50